Physician profile
Jonathan B Bingham
NPI 1063449809
$1,999.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.73 · 2020: $200 · 2021: $670 · 2022: $589 · 2023: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $343.19 | 2021-2023 | Lynparza |
| Astellas Pharma US INC | $341.47 | 2020-2023 | Myrbetriq, Veozah |
| Glaxosmithkline, LLC. | $249.54 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $145.79 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.70 | 2020-2022 | |
| Blue Earth Diagnostics | $119.13 | 2021-2022 | |
| Kerecis Limited | $100.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Boston Scientific Corporation | $94.73 | 2023 | Rezum Generator |
| Pfizer INC. | $75.24 | 2020-2022 | |
| Janssen Biotech, INC. | $56.17 | 2022-2023 | |
| Olympus America INC. | $55.54 | 2021-2023 | Soltive |
| Dendreon Pharmaceuticals LLC | $52.61 | 2021-2023 | Provenge |
| Medtronic, INC. | $50.85 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $37.88 | 2023 | Gemtesa |
| Mindray Ds USA, INC. | $35.38 | 2023 | A7 Anesthesia System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $28.63 | 2020 | |
| Urogen Pharma, INC. | $17.79 | 2022 | |
| Urovant Sciences INC | $17.29 | 2022 | |
| Antares Pharma, INC. | $14.25 | 2022 | |
| Allergan, INC. | $13.73 | 2019 | |
| Metuchen Pharmaceuticals | $13.39 | 2020 | |
| Photocure INC | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.